Agenda
7:30 AM -
Registration & Breakfast
Hinxton Hall Conference Center at The Wellcome Genome Campus
8:30 AM -
8:35 AM -
8:40 AM -
Expanding the Druggable Genome with Small Molecules
Nello Mainolfi (Kymera)
Hosted by Karen Akinsanya (Schrödinger)
9:00 AM -
Sourcing Innovation Across Academia, Biotech, and Pharma
Mary Lynne Hedley (Third Rock), Carol Gallagher (formerly NEA), Deborah Baron (Pfizer)
Hosted by George Golumbeski (DROIA)
9:30 AM -
Discovery Stories and Technologies: Single Cells to AI
Roger Perlmutter (Eikon), Mark Kotter (University of Cambridge), David Reese (Amgen)
Chaired by Abraham Heifets (Atomwise)
10:25 AM -
Refreshment Break
10:50 AM -
Public Investors Weigh In on The Market and Current Innovation
Rajiv Kaul (Fidelity), Andy Acker (Janus Henderson), Phill Gross (Adage)
Hosted by Terry Coyne (Royalty Pharma)
11:30 AM -
Every Breath You Take: Oxygen Sensing and Where it Leads Us
Peter Ratcliffe (University of Oxford)
Fireside chat with Patrick Maxwell (University of Cambridge)
12:05 PM -
The New Weight Loss Drugs and Their Global Impact on Obesity
Karin Conde-Knape (Novo Nordisk)
Hosted by Brienne Kugler (Royalty Pharma)
12:25 PM -
Decoding a Billion
Shankar Balasubramanian (University of Cambridge)
Fireside chat with Siddhartha Mukherjee (Columbia University)
1:00 PM -
Lunch
1:45 PM -
Using Yale Science to Hijack your Liver:
Biohaven’s New Approach to Immune-Mediated Diseases
David Spiegel (Yale University)
Hosted by Marshall Urist (Royalty Pharma)
2:05 PM -
Will R&D Ever Deliver and, if so, Where the Hell is it Going?
Christian Rommel (Bayer), Mene Pangalos (formerly AstraZeneca)
Hosted by John Maraganore (formerly Alnylam)
2:35 PM -
CAR-T Cell Therapy in Autoimmune Disease
Georg Schett (FAU Erlangen Nürnberg)
Hosted by Jim Reddoch (Royalty Pharma)
2:55 PM -
Development of an Antisense Drug for a Deadly Neurodegenerative Disease
Adrian Krainer (Cold Spring Harbor Laboratory)
Hosted by Nataly Hastings (University of Cambridge)
3:15 PM -
Refreshment Break
3:30 PM -
Novel Oncology Approaches
Jak Knowles (Affini-T Therapeutics), Troy Wilson (Kura Oncology), Zachary Hornby (Boundless Bio)
Chaired by Padmanee Sharma (MD Anderson)
4:25 PM -
Paying for Innovation
Jeffrey Berkowitz (Real Endpoints)
Hosted by Rachel Mears (Jeito Capital)
4:45 PM -
Private Markets and Mergers: Heating Up or Overheated?
Francesco De Rubertis (Medicxi), Otello Stampacchia (Omega), Srini Akkaraju (Samsara)
Hosted by Oleg Nodelman (EcoR1)
